| Year |
Citation |
Score |
| 2011 |
Cheng Y, Dai C, Peng H, Zheng S, Jin S, Wang B. Design, synthesis, and polymerase-catalyzed incorporation of click-modified boronic acid-TTP analogues. Chemistry, An Asian Journal. 6: 2747-52. PMID 21887745 DOI: 10.1002/Asia.201100229 |
0.671 |
|
| 2010 |
King-Keller S, Li M, Smith A, Zheng S, Kaur G, Yang X, Wang B, Docampo R. Chemical validation of phosphodiesterase C as a chemotherapeutic target in Trypanosoma cruzi, the etiological agent of Chagas' disease. Antimicrobial Agents and Chemotherapy. 54: 3738-45. PMID 20625148 DOI: 10.1128/Aac.00313-10 |
0.677 |
|
| 2009 |
Kamio M, Ko KC, Zheng S, Wang B, Collins SL, Gadda G, Tai PC, Derby CD. The chemistry of escapin: identification and quantification of the components in the complex mixture generated by an L-amino acid oxidase in the defensive secretion of the sea snail Aplysia californica. Chemistry (Weinheim An Der Bergstrasse, Germany). 15: 1597-603. PMID 19130530 DOI: 10.1002/Chem.200801696 |
0.501 |
|
| 2009 |
Kamio M, Ko K, Zheng S, Wang B, Collins S, Gadda G, Tai P, Derby C. Cover Picture: The Chemistry of Escapin: Identification and Quantification of the Components in the Complex Mixture Generated by an L-Amino Acid Oxidase in the Defensive Secretion of the Sea SnailAplysia californica(Chem. Eur. J. 7/2009) Chemistry - a European Journal. 15: 1535-1535. DOI: 10.1002/Chem.200990013 |
0.472 |
|
| 2008 |
Du L, Li M, Zheng S, Wang B. Rational Design of a Fluorescent Hydrogen Peroxide Probe Based on the Umbelliferone Fluorophore. Tetrahedron Letters. 49: 3045-3048. PMID 19081820 DOI: 10.1016/J.Tetlet.2008.03.063 |
0.654 |
|
| 2008 |
Zheng S, Kaur G, Wang H, Li M, Macnaughtan M, Yang X, Reid S, Prestegard J, Wang B, Ke H. Design, synthesis, and structure - Activity relationship, molecular modeling, and NMR studies of a series of phenyl alkyl ketones as highly potent and selective phosphodiesterase-4 inhibitors Journal of Medicinal Chemistry. 51: 7673-7688. PMID 19049349 DOI: 10.1021/Jm701635J |
0.692 |
|
| 2007 |
Zheng SL, Lin N, Reid S, Wang B. Effect of extended conjugation with a phenylethynyl group on the fluorescent properties of water-soluble arylboronic acids. Tetrahedron. 63: 5427-5436. PMID 19568321 DOI: 10.1016/J.Tet.2007.04.035 |
0.629 |
|
| 2007 |
Zhang Y, Eric Ballard C, Zheng SL, Gao X, Ko KC, Yang H, Brandt G, Lou X, Tai PC, Lu CD, Wang B. Design, synthesis, and evaluation of efflux substrate-metal chelator conjugates as potential antimicrobial agents. Bioorganic & Medicinal Chemistry Letters. 17: 707-11. PMID 17150357 DOI: 10.1016/J.Bmcl.2006.10.094 |
0.612 |
|
| 2006 |
Zheng S, Reid S, Lin N, Wang B. Microwave-assisted synthesis of ethynylarylboronates for the construction of boronic acid-based fluorescent sensors for carbohydrates Tetrahedron Letters. 47: 2331-2335. DOI: 10.1016/J.Tetlet.2006.02.012 |
0.581 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Xing N, Chen C, Zhong Q, Zheng S, Wang G, He L. Design, Synthesis, and Antitumor Activity of a Series of Novel 4-(Aromatic Sulfonyl)-1-oxa-4-azaspiro[4.5]deca-6,9-dien-8-ones. Molecules (Basel, Switzerland). 25. PMID 33233396 DOI: 10.3390/molecules25225459 |
0.288 |
|
| 2015 |
Zhao LM, Ma FY, Jin HS, Zheng S, Zhong Q, Wang G. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach. European Journal of Medicinal Chemistry. 102: 303-9. PMID 26291039 DOI: 10.1016/j.ejmech.2015.08.006 |
0.27 |
|
| 2022 |
Yin H, Chen Y, Zhong Q, Zheng S, Wang G, He L. Design, synthesis, and antitumor study of a series of novel 1-Oxa-4-azaspironenone derivatives. Bioorganic & Medicinal Chemistry Letters. 74: 128925. PMID 35944852 DOI: 10.1016/j.bmcl.2022.128925 |
0.269 |
|
| 2019 |
Yang Z, Zhong Q, Zheng S, Wang G, He L. Synthesis and Antitumor Activity of a Series of Novel 1-Oxa-4-azaspiro[4,5]deca-6,9-diene-3,8-dione Derivatives. Molecules (Basel, Switzerland). 24. PMID 30866506 DOI: 10.3390/molecules24050936 |
0.266 |
|
| 2016 |
Li Y, Cao TT, Guo S, Zhong Q, Li CH, Li Y, Dong L, Zheng S, Wang G, Yin SF. Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition. Molecules (Basel, Switzerland). 21. PMID 27331805 DOI: 10.3390/molecules21060771 |
0.262 |
|
| 2022 |
Chen C, Luo Y, Yin H, Zhong Q, Zheng S, Liu R, Zhao C, Wang G, He L. Design, synthesis, and antitumor activity evaluation of novel acyl sulfonamide spirodienones. Bioorganic & Medicinal Chemistry. 60: 116626. PMID 35255412 DOI: 10.1016/j.bmc.2022.116626 |
0.254 |
|
| 2017 |
Liu J, Zheng S, Guo S, Zhang C, Zhong Q, Zhang Q, Ma P, Skripnikova EV, Bratton MR, Wiese TE, Wang G. Rational Design of a Boron-Modified Triphenylethylene (GLL398) as an Oral Selective Estrogen Receptor Downregulator. Acs Medicinal Chemistry Letters. 8: 102-106. PMID 28105283 DOI: 10.1021/Acsmedchemlett.6B00410 |
0.251 |
|
| 2015 |
Zhao LM, Ma FY, Jin HS, Zheng S, Zhong Q, Wang G. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach European Journal of Medicinal Chemistry. 102: 303-309. DOI: 10.1016/j.ejmech.2015.08.006 |
0.249 |
|
| 2020 |
Luo L, Jia JJ, Zhong Q, Zhong X, Zheng S, Wang G, He L. Synthesis and anticancer activity evaluation of naphthalene-substituted triazole spirodienones. European Journal of Medicinal Chemistry. 113039. PMID 33261898 DOI: 10.1016/j.ejmech.2020.113039 |
0.249 |
|
| 2014 |
Zheng S, Zhong Q, Xi Y, Mottamal M, Zhang Q, Schroeder RL, Sridhar J, He L, McFerrin H, Wang G. Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. Journal of Medicinal Chemistry. 57: 6653-67. PMID 25007006 DOI: 10.1021/jm500724x |
0.244 |
|
| 2017 |
Gu L, Wang P, Zhong Q, Deng Y, Xie J, Liu F, Xiao F, Zheng S, Chen Y, Wang G, He L. Copper salt-catalyzed formation of a novel series of triazole-spirodienone conjugates with potent anticancer activity. Rsc Advances. 7: 9412-9416. PMID 30740218 DOI: 10.1039/C6RA24764D |
0.243 |
|
| 2014 |
Zheng S, Zhong Q, Mottamal M, Zhang Q, Zhang C, Lemelle E, McFerrin H, Wang G. Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. Journal of Medicinal Chemistry. 57: 3369-81. PMID 24669888 DOI: 10.1021/jm500002k |
0.242 |
|
| 2016 |
Wang R, Zhang X, Chen C, Chen G, Zhong Q, Zhang Q, Zheng S, Wang G, Chen QH. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents. European Journal of Medicinal Chemistry. 110: 164-180. PMID 26827161 DOI: 10.1016/J.Ejmech.2016.01.017 |
0.223 |
|
| 2015 |
Wang R, Chen C, Zhang X, Zhang C, Zhong Q, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents. Journal of Medicinal Chemistry. 58: 4713-26. PMID 25961334 DOI: 10.1021/Acs.Jmedchem.5B00470 |
0.219 |
|
| 2020 |
Luo L, Zhong Q, Guo S, Zhang C, Zhang Q, Zheng S, He L, Wang G. Development of a bioavailable boron-containing PI-103 Bioisostere, PI-103BE. Bioorganic & Medicinal Chemistry Letters. 30: 127258. PMID 32527558 DOI: 10.1016/j.bmcl.2020.127258 |
0.208 |
|
| 2016 |
Zhang X, Wang R, Perez GR, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents. Bioorganic & Medicinal Chemistry. PMID 27543391 DOI: 10.1016/J.Bmc.2016.08.006 |
0.204 |
|
| 2012 |
Li X, Zheng SL, Li X, Li JL, Qiang O, Liu R, He L. Synthesis and anti-breast cancer activity of new indolylquinone derivatives. European Journal of Medicinal Chemistry. 54: 42-8. PMID 22658083 DOI: 10.1016/j.ejmech.2012.04.019 |
0.202 |
|
| 2023 |
Zhong X, Deng H, Long M, Yin H, Zhong Q, Zheng S, Gong T, He L, Wang G, Sun Q. Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors. Bioorganic Chemistry. 138: 106597. PMID 37245245 DOI: 10.1016/j.bioorg.2023.106597 |
0.198 |
|
| 2019 |
Chen G, Patanapongpibul M, Jiang Z, Zhang Q, Zheng S, Wang G, White JD, Chen QH. Synthesis and antiproliferative evaluation of new zampanolide mimics. Organic & Biomolecular Chemistry. PMID 30924817 DOI: 10.1039/C9Ob00556K |
0.195 |
|
| 2020 |
Xing N, Huang J, Wang P, Luo L, Zheng S, He L. Novel one-pot synthesis of imidazolinones from esters: a concise synthesis of GSK2137305. Organic & Biomolecular Chemistry. PMID 32147677 DOI: 10.1039/c9ob02743b |
0.188 |
|
| 2018 |
Chen G, Wang R, Vue B, Patanapongpibul M, Zhang Q, Zheng S, Wang G, White JD, Chen QH. Optimized synthesis and antiproliferative activity of desTHPdactylolides. Bioorganic & Medicinal Chemistry. PMID 29784275 DOI: 10.1016/J.Bmc.2018.05.026 |
0.187 |
|
| 2020 |
Chen Y, Liu X, Shi W, Zheng S, Wang G, He L. One-Pot Synthesis of Seven-membered Heterocyclic Derivatives of Diazepines Involving Copper-Catalyzed Rearrangement Cascade Allyl-Amination. The Journal of Organic Chemistry. PMID 32182067 DOI: 10.1021/acs.joc.9b02710 |
0.183 |
|
| 2013 |
Zheng S, Zhong Q, Jiang Q, Mottamal M, Zhang Q, Zhu N, Burow ME, Worthylake RA, Wang G. Discovery of a Series of Thiazole Derivatives as Novel Inhibitors of Metastatic Cancer Cell Migration and Invasion. Acs Medicinal Chemistry Letters. 4: 191-196. PMID 23526571 DOI: 10.1021/Ml300322N |
0.175 |
|
| 2010 |
Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, et al. Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. Journal of Medicinal Chemistry. 53: 6153-63. PMID 20669983 DOI: 10.1021/Jm100610W |
0.174 |
|
| 2014 |
Samaan N, Zhong Q, Fernandez J, Chen G, Hussain AM, Zheng S, Wang G, Chen QH. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. European Journal of Medicinal Chemistry. 75: 123-31. PMID 24531225 DOI: 10.1016/J.Ejmech.2014.01.041 |
0.173 |
|
| 2020 |
Huang J, Luo L, Xing N, Gu L, Li C, Han Q, Zheng S, He L. Novel synthesis of divergent aryl imidazoles from ketones involving copper-catalyzed α-amination and oxidative C-C bond cleavage. Rsc Advances. 10: 13815-13819. PMID 35492973 DOI: 10.1039/d0ra01408g |
0.172 |
|
| 2016 |
Li X, Chen G, Zhang X, Zhang Q, Zheng S, Wang G, Chen QH. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models. Bioorganic & Medicinal Chemistry Letters. PMID 27476422 DOI: 10.1016/J.Bmcl.2016.07.050 |
0.17 |
|
| 2022 |
Zheng S, Liu J, Kang B, Wang G. Design and synthesis of a novel ZB716-d6 as a stable isotopically labeled internal standard. Synthetic Communications. 52: 1441-1447. PMID 36420104 DOI: 10.1080/00397911.2022.2095212 |
0.169 |
|
| 2017 |
Komati R, Spadoni D, Zheng S, Sridhar J, Riley KE, Wang G. Ligands of Therapeutic Utility for the Liver X Receptors. Molecules (Basel, Switzerland). 22. PMID 28067791 DOI: 10.3390/molecules22010088 |
0.167 |
|
| 2003 |
Cheung WH, Zheng SL, Yu WY, Zhou GC, Che CM. Ruthenium porphyrin catalyzed intramolecular carbenoid C[bond]H insertion. Stereoselective synthesis of cis-disubstituted oxygen and nitrogen heterocycles. Organic Letters. 5: 2535-8. PMID 12841774 DOI: 10.1021/Ol034806Q |
0.166 |
|
| 2015 |
Liu J, Pham PT, Skripnikova EV, Zheng S, Lovings LJ, Wang Y, Goyal N, Bellow SM, Mensah LM, Chatters AJ, Bratton MR, Wiese TE, Zhao M, Wang G, Foroozesh M. A Ligand-Based Drug Design, Discovery of 4-Trifluoromethyl-7,8-Pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2. Journal of Medicinal Chemistry. PMID 26222195 DOI: 10.1021/Acs.Jmedchem.5B00494 |
0.163 |
|
| 2018 |
Vue B, Zhang S, Vignau A, Chen G, Zhang X, Diaz W, Zhang Q, Zheng S, Wang G, Chen QH. -Aminoalkyl--Trimethyl-2,3-Dehydrosilybins: Synthesis and In Vitro Effects Towards Prostate Cancer Cells. Molecules (Basel, Switzerland). 23. PMID 30501133 DOI: 10.3390/Molecules23123142 |
0.159 |
|
| 2016 |
Liu J, Zheng S, Akerstrom VL, Yuan C, Ma Y, Zhong Q, Zhang C, Zhang Q, Guo S, Ma P, Skripnikova EV, Bratton MR, Pannuti A, Miele L, Wiese TE, et al. Fulvestrant-3 Boronic Acid (ZB716): An Orally Bioavailable Selective Estrogen Receptor Downregulator (SERD). Journal of Medicinal Chemistry. PMID 27529700 DOI: 10.1021/Acs.Jmedchem.6B00753 |
0.159 |
|
| 2015 |
Mottamal M, Zheng S, Huang TL, Wang G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules (Basel, Switzerland). 20: 3898-941. PMID 25738536 DOI: 10.3390/molecules20033898 |
0.158 |
|
| 2018 |
Guo S, Zhang C, Bratton M, Mottamal M, Liu J, Ma P, Zheng S, Zhong Q, Yang L, Wiese TE, Wu Y, Ellis MJ, Matossian M, Burow ME, Miele L, et al. ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models. Oncotarget. 9: 6924-6937. PMID 29467940 DOI: 10.18632/Oncotarget.24023 |
0.153 |
|
| 2016 |
Zhang S, Vue B, Huang M, Zhang X, Lee T, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells. Bioorganic & Medicinal Chemistry Letters. PMID 27261177 DOI: 10.1016/J.Bmcl.2016.05.069 |
0.152 |
|
| 2017 |
Zhang X, Guo S, Chen C, Perez GR, Zhang C, Patanapongpibul M, Subrahmanyam N, Wang R, Keith J, Chen G, Dong Y, Zhang Q, Zhong Q, Zheng S, Wang G, et al. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies. European Journal of Medicinal Chemistry. 137: 263-279. PMID 28601720 DOI: 10.1016/J.Ejmech.2017.05.062 |
0.149 |
|
| 2018 |
Patanapongpibul M, Zhang C, Chen G, Guo S, Zhang Q, Zheng S, Wang G, Chen QH. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer. Bioorganic & Medicinal Chemistry. PMID 30121214 DOI: 10.1016/J.Bmc.2018.08.018 |
0.146 |
|
| 2022 |
Jia J, Yin H, Chen C, Hu M, Zhong Q, Zheng S, Zhang W, Li H, Xu L, Wang G, He L. Design, synthesis, and evaluation of a novel series of mono-indolylbenzoquinones derivatives for the potential treatment of breast cancer. European Journal of Medicinal Chemistry. 237: 114375. PMID 35477142 DOI: 10.1016/j.ejmech.2022.114375 |
0.142 |
|
| 2017 |
Li X, Lee M, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents. Bioorganic & Medicinal Chemistry. PMID 28760528 DOI: 10.1016/J.Bmc.2017.07.022 |
0.141 |
|
| 2015 |
Zhang C, Zhong Q, Zhang Q, Zheng S, Miele L, Wang G. Boronic prodrug of endoxifen as an effective hormone therapy for breast cancer. Breast Cancer Research and Treatment. 152: 283-91. PMID 26071758 DOI: 10.1007/S10549-015-3461-9 |
0.139 |
|
| 2017 |
Wang R, Zhang X, Chen C, Chen G, Sarabia C, Zhang Q, Zheng S, Wang G, Chen QH. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models. European Journal of Medicinal Chemistry. 133: 208-226. PMID 28388523 DOI: 10.1016/J.Ejmech.2017.03.067 |
0.13 |
|
| 2015 |
Vue B, Zhang S, Zhang X, Parisis K, Zhang Q, Zheng S, Wang G, Chen QH. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations. European Journal of Medicinal Chemistry. 109: 36-46. PMID 26748997 DOI: 10.1016/J.Ejmech.2015.12.041 |
0.129 |
|
| 2015 |
Xiong P, Wang R, Zhang X, DeLa Torre E, Leon F, Zhang Q, Zheng S, Wang G, Chen QH. Design, Synthesis, and Evaluation of Genistein Analogues as Anti-Cancer Agents. Anti-Cancer Agents in Medicinal Chemistry. PMID 25991428 DOI: 10.2174/1871520615666150520142437 |
0.128 |
|
| 2019 |
Rajaram P, Jiang Z, Chen G, Rivera A, Phasakda A, Zhang Q, Zheng S, Wang G, Chen QH. Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models. Bioorganic Chemistry. 87: 227-239. PMID 30904813 DOI: 10.1016/J.Bioorg.2019.03.047 |
0.115 |
|
| 2002 |
Zheng SL, Yu WY, Che CM. Ruthenium(II) porphyrin catalyzed formation of (Z)-4-alkyloxycarbonyl- methylidene-1,3-dioxolanes from gamma-alkoxy-alpha-diazo-beta-ketoesters. Organic Letters. 4: 889-92. PMID 11893178 DOI: 10.1021/Ol010283F |
0.112 |
|
| 2018 |
Li X, Zhang C, Guo S, Rajaram P, Lee M, Chen G, Fong R, Gonzalez A, Zhang Q, Zheng S, Wang G, Chen QH. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents. European Journal of Medicinal Chemistry. 157: 978-993. PMID 30165345 DOI: 10.1016/J.Ejmech.2018.08.047 |
0.104 |
|
| 2019 |
Zhang C, Guo S, Zhong Q, Zhang Q, Hossain A, Zheng S, Wang G. Metabolism and Pharmacokinetic Study of the Boron-Containing Prodrug of Belinostat (ZL277), a Pan HDAC Inhibitor with Enhanced Bioavailability. Pharmaceuticals (Basel, Switzerland). 12. PMID 31817969 DOI: 10.3390/ph12040180 |
0.104 |
|
| 2014 |
Strong AL, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Burow ME, Bunnell BA, Wang G. Design, synthesis, and osteogenic activity of daidzein analogs on human mesenchymal stem cells. Acs Medicinal Chemistry Letters. 5: 143-8. PMID 24900787 DOI: 10.1021/Ml400397K |
0.1 |
|
| 2017 |
Vue B, Zhang X, Lee T, Nair N, Zhang S, Chen G, Zhang Q, Zheng S, Wang G, Chen QH. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models. Bioorganic & Medicinal Chemistry. PMID 28756013 DOI: 10.1016/J.Bmc.2017.07.035 |
0.098 |
|
| 2013 |
Jiang Q, Zheng S, Wang G. Development of new estrogen receptor-targeting therapeutic agents for tamoxifen-resistant breast cancer. Future Medicinal Chemistry. 5: 1023-35. PMID 23734685 DOI: 10.4155/fmc.13.63 |
0.094 |
|
| 2018 |
Zheng S, Guo S, Zhong Q, Zhang C, Liu J, Yang L, Zhang Q, Wang G. Biocompatible Boron-Containing Prodrugs of Belinostat for the Potential Treatment of Solid Tumors. Acs Medicinal Chemistry Letters. 9: 149-154. PMID 29456804 DOI: 10.1021/acsmedchemlett.7b00504 |
0.089 |
|
| 2015 |
Zhong Q, Zhang C, Zhang Q, Miele L, Zheng S, Wang G. Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status. Bmc Cancer. 15: 625. PMID 26354796 DOI: 10.1186/S12885-015-1621-2 |
0.087 |
|
| 2017 |
Zhang C, Guo S, Yang L, Liu J, Zheng S, Zhong Q, Zhang Q, Wang G. Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD). Oncotarget. 8: 103874-103889. PMID 29262607 DOI: 10.18632/oncotarget.21808 |
0.084 |
|
| 2012 |
Jiang Q, Zhong Q, Zhang Q, Zheng S, Wang G. Boron-Based 4-Hydroxytamoxifen Bioisosteres for Treatment of de Novo Tamoxifen Resistant Breast Cancer. Acs Medicinal Chemistry Letters. 3: 392-396. PMID 23864928 DOI: 10.1021/ml3000287 |
0.083 |
|
| 2015 |
Zheng S, Liu J, Wu Y, Huang TL, Wang G. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics. Future Medicinal Chemistry. 7: 2485-505. PMID 26670195 DOI: 10.4155/fmc.15.159 |
0.066 |
|
| 2014 |
Strong AL, Ohlstein JF, Jiang Q, Zhang Q, Zheng S, Boue SM, Elliott S, Gimble JM, Burow ME, Wang G, Bunnell BA. Novel daidzein analogs enhance osteogenic activity of bone marrow-derived mesenchymal stem cells and adipose-derived stromal/stem cells through estrogen receptor dependent and independent mechanisms. Stem Cell Research & Therapy. 5: 105. PMID 25168698 DOI: 10.1186/Scrt493 |
0.057 |
|
| 2017 |
Strong AL, Bateman ME, Jones RB, Dutreil MF, Bowles AC, Budnick IM, Zheng S, Hayes DJ, Levi B, Gimble JM, Burow ME, Wang G, McNulty MA, Bunnell BA. Daidzein analog 2l enhances osteogenic differentiation of BMSCs and ASCs seeded on PLGA scaffolds and heals critical size calvarial defects Cell and Gene Therapy Insights. 3: 197-210. DOI: 10.18609/cgti.2017.032 |
0.046 |
|
| 2018 |
Wu K, Yu X, Huang Z, Zhu D, Yi X, Wu YL, Hao Q, Kemp KT, Elshimali Y, Iyer R, Nguyen KT, Zheng S, Chen G, Chen QH, Wang G, et al. Targeting of PP2Cδ by a small molecule C23 inhibits high glucose-induced breast cancer progression in vivo. Antioxidants & Redox Signaling. PMID 29808718 DOI: 10.1089/Ars.2017.7486 |
0.044 |
|
| 2023 |
Ruan B, Zhou T, Yuan Z, Singh J, Teng J, Zheng S, Zhang J. Effects of Curing Conditions on Splitting Tensile Behavior and Microstructure of Cemented Aeolian Sand Reinforced with Polypropylene Fiber. Materials (Basel, Switzerland). 16. PMID 37834484 DOI: 10.3390/ma16196347 |
0.024 |
|
| Hide low-probability matches. |